Breast Interventionism
Service description
It is currently estimated that 1 in 8 women will develop breast cancer in their lifetime. In Spain alone, 25,000 new cases are diagnosed each year, according to AECC. Despite the data, mortality from this type of tumor decreases annually thanks to advances in early diagnosis and treatment.
Affidea has created the women's unit, which focuses on the development of a care model where the patient will find a comprehensive and personalized care from the hand of a multidisciplinary team of specialists who have the latest technology.
Some of our most outstanding treatments are:
Corebiopsy by stereotaxy
Vacuum biopsy by stereotaxy (BAV)
Placement of harpoon for stereotaxy-guided surgery guide.
Stereotactic-guided echovisible titanium clip placement
Fine needle aspiration puncture (FNA)
Biopsy, core biopsy or thru-cut biopsy: core needle puncture
Placement of harpoon for ultrasound-guided surgery guide
Ultrasound-guided echo-visible titanium clip placement
Vacuum-assisted breast biopsy (VAB) guided by magnetic resonance imaging (MRI)
Magnetic resonance-guided surgical guide harpoon placement
MRI-guided echo-visible titanium clip placement
Biopsy by tomosynthesis
Corebiopsy by tomosynthesis
BAV or Tomosynthesis Vacuum Assisted Biopsy by Tomosynthesis
Affidea Group is a leader in advanced diagnostic imaging services and cancer treatment in Europe.